Show simple item record

dc.contributor.authorPredazzi, I.
dc.contributor.authorMango, R.
dc.contributor.authorNorata, Giuseppe
dc.contributor.authorDi Daniele, N.
dc.contributor.authorSergi, D.
dc.contributor.authorRomeo, F.
dc.contributor.authorNovelli, G.
dc.identifier.citationPredazzi, I. and Mango, R. and Norata, G. and Di Daniele, N. and Sergi, D. and Romeo, F. and Novelli, G. 2013. Pharmacogenetics in cardiovascular disorders: An update on the principal drugs. American Journal of Cardiovascular Drugs. 13 (2): pp. 79-85.

In the coming years, genomics will impact clinical practice in multiple ways. However, one of the most important applications will be in the determination of the best treatments in personalized medicine. This is, in fact, one of the fields in which genetic variants have already been most successful and useful to clinicians. Here, we briefly review the current state of the art on pharmacogenomics and its applications to modern cardiovascular medicine. © 2013 Springer International Publishing Switzerland.

dc.titlePharmacogenetics in cardiovascular disorders: An update on the principal drugs
dc.typeJournal Article
dcterms.source.titleAmerican Journal of Cardiovascular Drugs
curtin.departmentSchool of Biomedical Sciences
curtin.accessStatusFulltext not available

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record